Surveilalnce for uveal melanoma – pro
No high-level studies are available to inform the most appropriate monitoring for patients who have undergone treatment for uveal melanoma. As such, no consensus has been reached within the ophthalmic or oncologic community about the role of surveillance for detection of metastases in those patients. Because evidence concerning surgical resection has suggested improved survival102, there is a trend toward the use of rigorous follow-up in high-risk patients. The median time to develop liver metastases is approximately 2.5 years; management of metastatic disease might therefore achieve more favourable outcomes when the metastasis is detected early.
Weis E, Salopek TG, McKinnon JG, et al. Management of uveal melanoma: a consensus-based provincial clinical practice guideline. Curr Oncol. 2016;23(1):e57-64.